Publicacions (17) Publicacions de VICTOR LATORRE ROSELLO

2022

  1. Identification of Cytoplasmic Chaperone Networks Relevant for Respiratory Syncytial Virus Replication

    Frontiers in Microbiology, Vol. 13

2021

  1. Adoptive transfer of ex vivo expanded SARS-CoV-2-specific cytotoxic lymphocytes: A viable strategy for COVID-19 immunosuppressed patients?

    Transplant Infectious Disease, Vol. 23, Núm. 4

  2. Globally defining the effects of mutations in a picornavirus capsid

    eLife, Vol. 10, pp. 1-56

  3. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 3, pp. 485-494

  4. Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS-CoV-2 neutralizing activity of sera

    Journal of Medical Virology, Vol. 93, Núm. 4, pp. 2301-2306

2020

  1. HOX paralogs selectively convert binding of ubiquitous transcription factors into tissuespecific patterns of enhancer activation

    PLoS Genetics, Vol. 16, Núm. 12

  2. SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients

    Journal of Clinical Virology, Vol. 131

2018

  1. Chaperoning the mononegavirales: Current knowledge and future directions

    Viruses, Vol. 10, Núm. 12

2017

  1. A tissue-specific, Gata6-driven transcriptional program instructs remodeling of the mature arterial tree

    eLife, Vol. 6

  2. Dysfunctional Skin-Derived Glucocorticoid Synthesis Is a Pathogenic Mechanism of Psoriasis

    Journal of Investigative Dermatology, Vol. 137, Núm. 8, pp. 1630-1637

2016

  1. A distal 594 bp ECR specifies Hmx1 expression in pinna and lateral facial morphogenesis and is regulated by the Hox-Pbx-Meis complex

    Development (Cambridge), Vol. 143, Núm. 14, pp. 2582-2592

2015

  1. Glucocorticoid receptor and Klf4 co-regulate anti-inflammatory genes in keratinocytes

    Molecular and Cellular Endocrinology, Vol. 412, pp. 281-289

2013

  1. Epidermal inactivation of the glucocorticoid receptor triggers skin barrier defects and cutaneous inflammation

    Journal of Investigative Dermatology, Vol. 133, Núm. 2, pp. 361-370

  2. Selective ablation of glucocorticoid receptor in mouse keratinocytes increases susceptibility to skin tumorigenesis

    Journal of Investigative Dermatology, Vol. 133, Núm. 12, pp. 2771-2779

2012

  1. Chromosome segregation in Archaea mediated by a hybrid DNA partition machine

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Núm. 10, pp. 3754-3759

  2. Keratinocyte-targeted overexpression of the glucocorticoid receptor delays cutaneous wound healing

    PLoS ONE, Vol. 7, Núm. 1

2010

  1. Glucocorticoid receptor regulates overlapping and differential gene subsets in developing and adult skin

    Molecular Endocrinology, Vol. 24, Núm. 11, pp. 2166-2178